Vator Securities successfully completes advisory mission for Vikingaliv
Vator Securities acted as exclusive financial advisor for Vikingaliv and assisted with obtaining both bank financing and share capital.
Read More
Vator Securities successfully completes advisory mission for Immunovia
Immunovia AB is a Swedish molecular diagnostics company that has developed what can become the world’s first robust test for early diagnosis of pancreatic cancer, which is the fourth deadliest cancer form in the world.
Read More
Vator Securities successfully completes advisory mission for IRRAS
IRRAS has developed a unique pump and catheter system for efficient drainage of fluids from the body and for local administration of drugs in the body.
Read More
Vator Securities successfully completes advisory mission for Bio-Works Technologies
Bio-Works is a biotechnology company that develops, produces and sells innovative separation media products based on agarose to purify proteins, peptides and other biomolecules.
Read More